Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 6,750.00
-80.00 (-1.17%)
At close: Sep 16, 2025
Seoulin Bioscience Revenue
Seoulin Bioscience had revenue of 16.22B KRW in the quarter ending June 30, 2025, a decrease of -18.04%. This brings the company's revenue in the last twelve months to 71.00B, down -15.99% year-over-year. In the year 2024, Seoulin Bioscience had annual revenue of 75.41B, down -15.81%.
Revenue (ttm)
71.00B
Revenue Growth
-15.99%
P/S Ratio
0.82
Revenue / Employee
682.70M
Employees
104
Market Cap
58.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75.41B | -14.16B | -15.81% |
| Dec 31, 2023 | 89.57B | -15.14B | -14.46% |
| Dec 31, 2022 | 104.71B | 24.17B | 30.01% |
| Dec 31, 2021 | 80.54B | 15.45B | 23.74% |
| Dec 31, 2020 | 65.09B | 10.68B | 19.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |